Home » Andrology » Men's health » Prostate cancer “What’s up, Doc?” News on treatment on the unfavorable risk

Prostate cancer “What’s up, Doc?” News on treatment on the unfavorable risk

Prostate cancer. What’s up, Doc?

Two studies concerning the treatment of prostate cancer at intermediate risk group patients.

1) brachytherapy boost low dose to control better than the dose escalation radiation therapy in men with unfavorable-risk disease.

2) within 6 months of androgen deprivation therapy (ADT) added to radiotherapy leads to a significantly better biochemical progression-free survival and disease that radiation only about did for prostate cancer at intermediate risk.

For more information, visit

Prostate cancer: news on treatment and control options – CareAcross.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: